A New Study Finds That Ruxolitinib Cream 1.5% Is Effective for Most Patients With HS

The cream significantly reduced abscesses and inflammatory nodules, reaffirming its efficacy as a maintenance option for HS.

Related Keywords

California ,United States ,San Diego ,American ,Martinaj Porter ,Jim Lee ,Dmytro Flisak ,Beth Israel Deaconess Medical Center ,International Hidradenitis Suppurativa Severity Score System ,American Academy Of Dermatology ,American Academy ,Beth Israel Deaconess Medical ,